scispace - formally typeset
L

Lana S. Rothenburg

Researcher at Sunnybrook Health Sciences Centre

Publications -  12
Citations -  1498

Lana S. Rothenburg is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Apathy & Alzheimer's disease. The author has an hindex of 11, co-authored 12 publications receiving 1307 citations. Previous affiliations of Lana S. Rothenburg include University of Toronto.

Papers
More filters
Journal ArticleDOI

A Meta-Analysis of Cytokines in Alzheimer's Disease

TL;DR: The results strengthen the clinical evidence that AD is accompanied by an inflammatory response, particularly higher peripheral concentrations of IL-6, TNF-α, IL-1β, TGF-β,IL-12 and IL-18 and higher CSF concentrations of T GF-β.
Journal ArticleDOI

Methylphenidate for the Treatment of Apathy in Alzheimer Disease: Prediction of Response Using Dextroamphetamine Challenge

TL;DR: A randomized, double-blind, placebo-controlled crossover trial of methylphenidate in a sample of 13 apathetic AD patients, finding that psychostimulants may be effective in treating features of apathy in AD, and dopaminergic changes may predict response.
Journal ArticleDOI

A SPECT study of apathy in Alzheimer's disease

TL;DR: In this group of nondepressed outpatients meeting criteria for probable AD, apathetic subjects displayed significant perfusion differences compared to nonapathetic subjects.
Journal ArticleDOI

The Relationship Between Inflammatory Markers and Post Stroke Cognitive Impairment

TL;DR: A post stroke inflammatory response may be important in subacute, PSCI, and backward stepwise elimination linear regression showed that higher concentrations of serum CRP predicted lower post stroke global cognition.
Journal ArticleDOI

A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.

TL;DR: Valproate is not effective for the management of agitation in moderate-to-severe AD, and may be poorly tolerated in this population of institutionalized AD patients.